The latest in life sciences

We look at hot topics in life sciences, from the investment and deal environment, to incoming Brexit-related rules for medical devices, targeted treatments, and patent pools as a facilitator of the longed-for COVID-19 vaccine.

July 2020

6 Insights

6 Insights

How to prepare for the MHRA's new medical devices enforcement rules

Key actions you can take to prepare for the new enforcement rules.

More
Click here to find out more

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

An exploration of patent pools, R&D and current initiatives.

More
Click here to find out more

Placing medical devices on the UK market after the end of Brexit transition

Discussing incoming rules and MHRA guidance for placing medical devices on the market in Great Britain and Northern Ireland.

More
Click here to find out more

Private equity investment in life sciences sector

Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.

More
Click here to find out more

Targeted treatments – Part 4: patenting digital devices

Important advances are being driven by digital communications technology, particularly in the medical devices sector.

More
Click here to find out more

UK increases scrutiny of tech and life sciences deals

Mergers and acquisitions in the tech and life sciences sectors may be subject to closer scrutiny by the UK competition authority and by the UK government in future.

More
Click here to find out more

Return to

home

Go to Interface main hub